Tiziana Life Sciences TLSA Stock
Tiziana Life Sciences Price Chart
Tiziana Life Sciences TLSA Financial and Trading Overview
| Tiziana Life Sciences stock price | 0.78 USD |
| Previous Close | 0.75 USD |
| Open | 0.76 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 900 |
| Day's Range | 0.74 - 0.79 USD |
| 52 Week Range | 0.5 - 1.39 USD |
| Volume | 81.53K USD |
| Avg. Volume | 218.73K USD |
| Market Cap | 78.96M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.18 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.5 USD |
TLSA Valuation Measures
| Enterprise Value | 61.21M USD |
| Trailing P/E | N/A |
| Forward P/E | -15.700001 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 4.0256414 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -4.196 |
Trading Information
Tiziana Life Sciences Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -1.24% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.39 USD |
| 52 Week Low | 0.5 USD |
| 50-Day Moving Average | 0.87 USD |
| 200-Day Moving Average | 0.73 USD |
TLSA Share Statistics
| Avg. Volume (3 month) | 218.73K USD |
| Avg. Daily Volume (10-Days) | 462.26K USD |
| Shares Outstanding | 100.59M |
| Float | 56.14M |
| Short Ratio | 1.53 |
| % Held by Insiders | 43.00% |
| % Held by Institutions | 5.16% |
| Shares Short | 86.66K |
| Short % of Float | 0.13% |
| Short % of Shares Outstanding | 0.090% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 2499:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -24.21% |
| Return on Equity (ttm) | -50.60% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -14585000 USD |
| Net Income Avi to Common (ttm) | -15397000 USD |
| Diluted EPS (ttm) | -0.16 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 18.12M USD |
| Total Cash Per Share (mrq) | 0.18 USD |
| Total Debt (mrq) | 365K USD |
| Total Debt/Equity (mrq) | 1.87 USD |
| Current Ratio (mrq) | 3.644 |
| Book Value Per Share (mrq) | 0.195 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -19615000 USD |
| Levered Free Cash Flow (ttm) | -7930625 USD |
Profile of Tiziana Life Sciences
| Country | United States |
| State | N/A |
| City | London |
| Address | 14/15 Conduit Street |
| ZIP | W1S 2XJ |
| Phone | N/A |
| Website | https://www.tizianalifesciences.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 9 |
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti- receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody for the treatment of IL6-induced inflammation and to treat COVID-19 patients. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.Kingdom.
Q&A For Tiziana Life Sciences Stock
What is a current TLSA stock price?
Tiziana Life Sciences TLSA stock price today per share is 0.78 USD.
How to purchase Tiziana Life Sciences stock?
You can buy TLSA shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Tiziana Life Sciences?
The stock symbol or ticker of Tiziana Life Sciences is TLSA.
Which industry does the Tiziana Life Sciences company belong to?
The Tiziana Life Sciences industry is Biotechnology.
How many shares does Tiziana Life Sciences have in circulation?
The max supply of Tiziana Life Sciences shares is 56.3M.
What is Tiziana Life Sciences Price to Earnings Ratio (PE Ratio)?
Tiziana Life Sciences PE Ratio is now.
What was Tiziana Life Sciences earnings per share over the trailing 12 months (TTM)?
Tiziana Life Sciences EPS is -0.18 USD over the trailing 12 months.
Which sector does the Tiziana Life Sciences company belong to?
The Tiziana Life Sciences sector is Healthcare.
Tiziana Life Sciences TLSA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}